Anthrax immune globulin (Intravenous)
Medically reviewed by Drugs.com. Last updated on Dec 30, 2021.
Falsely elevated blood glucose measurements may occur during therapy in diabetic patients because of the maltose ingredient; this increases the risk of masked hypoglycemic episodes and over administration of insulin, potentially causing life-threatening hypoglycemia. To avoid maltose interference, monitor blood glucose during therapy with glucose-specific methods (ie, monitor and test strips) in diabetic patients. Thrombosis may occur with or without known risk factors. Risk of thrombosis is increased with advanced age, prolonged immobilization, hypercoagulable conditions, history of venous or arterial thrombosis, estrogen use, indwelling central vascular catheters, hyperviscosity, and cardiovascular risk factors . For patients at risk of thrombosis, administer IVIG at the minimum dose and infusion rate practicable. Ensure adequate hydration in patients before administration. Monitor for signs and symptoms of thrombosis and assess blood viscosity in patients at risk for hyperviscosity .
Commonly used brand name(s)
In the U.S.
- Anthrasil
Uses for anthrax immune globulin
Anthrax immune globulin belongs to a group of medicines known as immunizing agents. It is used to prevent or treat diseases that occur when your body has a weak immune system. Immune globulin contains antibodies that make your immune system stronger. It is used in combination with other medicines to treat inhalational anthrax in adults and children.
Anthrax is a serious disease that may cause death. It is spread by touching or eating something that is infected with the anthrax germ, such as animals, or by breathing in the anthrax germ.
Anthrax immune globulin is to be given only by or under the supervision of your doctor.
Before using anthrax immune globulin
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For anthrax immune globulin, the following should be considered:
Allergies
Tell your doctor if you have ever had any unusual or allergic reaction to anthrax immune globulin or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Pediatric
Appropriate studies on the relationship of age to the effects of anthrax immune globulin injection have not been performed in the pediatric population. Safety and efficacy have not been established in children 16 years of age and younger.
Geriatric
Appropriate studies have not been performed on the relationship of age to the effects of anthrax immune globulin injection in the geriatric population. Safety and efficacy have not been established.
Breastfeeding
There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.
Interactions with medicines
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction ..
